Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Harvard Business School
Johnson and Johnson
Merck
Mallinckrodt

Last Updated: November 28, 2022

Details for Patent: 7,887,844


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which drugs does patent 7,887,844 protect, and when does it expire?

Patent 7,887,844 protects ZMAX and is included in one NDA.

This patent has one patent family member in one country.

Summary for Patent: 7,887,844
Title:Multiparticulate crystalline drug compositions having controlled release profiles
Abstract:A multiparticulate for controlled release of a drug comprises crystalline drug, a glyceride having at least one alkylate substituent of at least 16 carbon atoms, and a poloxamer, wherein at least 70 wt % of the drug in the multiparticulate is crystalline.
Inventor(s): Appel; Leah E. (Bend, OR), Ray; Roderick J. (Bend, OR), Lyon; David K. (Bend, OR), West; James B. (Bend, OR), McCray; Scott B. (Bend, OR), Crew; Marshall D. (Bend, OR), Friesen; Dwayne T. (Bend, OR), Herbig; Scott M. (East Lyme, CT), Lo; Julian B. (Old Lyme, CT)
Assignee: Pfizer Inc. (New York, NY)
Application Number:11/004,168
Patent Claim Types:
see list of patent claims
Composition; Process; Use;

Drugs Protected by US Patent 7,887,844

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Pf Prism Cv ZMAX azithromycin FOR SUSPENSION, EXTENDED RELEASE;ORAL 050797-001 Jun 10, 2005 DISCN Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,887,844

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
World Intellectual Property Organization (WIPO) 2005053652 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Harvard Business School
Moodys
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.